MedPath

COMBINE (Acamprosate/Naltrexone)

Phase 3
Completed
Conditions
Alcoholism
Registration Number
NCT00006206
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

Combine is a multicenter, randomized clinical trial that will evaluate combinations of three interventions for treating alcohol dependence. The goal is to determine whether improvement in treatment outcomes can be achieved by various combinations of drug and behavioral interventions. Two of the interventions will consist of pharmacological treatment with naltrexone (Revia) or acamprosate (Campral). The third intervention is a multicomponent behavioral therapy including such components as motivational enhancement therapy, cognitive behavioral therapy, and referral to self-help groups, including AA. All three interventions will include a component supporting compliance to medications and reduction in drinking.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1375
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Percent days abstinent
Time to relapse to heavy drinking
Secondary Outcome Measures
NameTimeMethod
measures of drinking outcomes ((duration of abstinence, measures of frequency and intensity, et al.)
psychological assessments
quality of life
measures of adverse experiences

Trial Locations

Locations (12)

Substance Abuse Treatment Unit, Yale University

🇺🇸

New Haven, Connecticut, United States

University of Miami School of Medicine

🇺🇸

Miami, Florida, United States

Harvard University/McLean Hospital

🇺🇸

Belmont, Massachusetts, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Boston University School of Medicine

🇺🇸

Boston, Massachusetts, United States

Center on Alcoholism, Substance Abuse and Addiction, University of New Mexico

🇺🇸

Albuquerque, New Mexico, United States

Treatment and Research Center, University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Roger Williams Medical Center , Brown University

🇺🇸

Providence, Rhode Island, United States

Center for Alcohol Programs, Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Southwest Texas Addiction Research and Technology Center, University of Texas Health Science Center

🇺🇸

San Antonio, Texas, United States

Scroll for more (2 remaining)
Substance Abuse Treatment Unit, Yale University
🇺🇸New Haven, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.